Because apo B containing lipoprotein fractions are thought to be responsible for cholesterol deposition in atherosclerotic plaques (Schaefer and Asztalos, 2006 ▶), a reduction in LDL-C would be advantageous clinically in hypercholesterolemia. The gene discussed is APOB; the disease is Hypercholesterolemia.